The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 8.50
Ask: 9.00
Change: 0.81 (10.20%)
Spread: 0.50 (5.882%)
Open: 8.25
High: 8.75
Low: 8.25
Prev. Close: 7.94
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MicroSalt expands U.S. retail presence

17 May 2023 07:00

RNS Number : 6227Z
Tekcapital plc
17 May 2023
 

17 May 2023

Tekcapital Plc

("Tekcapital" or the "Group")

MicroSalt® expands the U.S. retail presence

of its low-sodium, full-flavor products

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products that can improve people's lives, is pleased to provide a commercial update from Microsalt Ltd ("Microsalt").

MicroSalt Ltd continues with its successful sales expansion of both its SaltMe! crisps and MicroSalt saltshakers with new placements in over 400 additional U.S. retail stores including Brookshire Brothers, Pete's Fresh Market, Heinen's, Dick's Fresh Market, Zerbos, Better Health Market, Tdych's Marketplace, Associated Supermarkets and a number of other natural independent retailers across the country.

"We are proud of our efforts thus far to build product distribution as it underscores the retail need for full flavor, low-sodium products. These efforts are working in parallel with our efforts to provide low-sodium products for private-labeled retail brands. Excess sodium consumption is one of the leading contributors to hypertension, and partnerships like this are the best way to provide consumers with great tasting products with less sodium," said Rick Guiney, CEO of MicroSalt.

About MicroSalt

MicroSalt is dedicated to innovating food technology solutions that enable people to live longer, healthier and happier lives. Its patented low-sodium salt delivers natural salt with approximately 50% less sodium and may be used by both consumers and food manufacturers who wish to decrease the amount of sodium in their food. MicroSalt is 100% natural, non-GMO, gluten free, Kosher and contains no potassium chloride. To learn more about MicroSalt and MicroSalt® products, please visit www.microsalt.co.

 

Tekcapital owns 97% of the share capital of MicroSalt Ltd. and 6,034,683 shares (78%) of MicroSalt Inc., its U.S. subsidiary.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc 

 Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon

microsalt@flagstaffcomms.com

 

 

+44 (0)207 129 1474

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving MicroSalt and/or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of MicroSalt and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of MicroSalt or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither MicroSalt nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRANKABNPBKDOPD
Date   Source Headline
6th May 20157:01 amRNSPlacing
1st May 20157:00 amRNSTotal Voting Rights
14th Apr 20157:00 amRNSTechnology Acquisition
10th Apr 20157:01 amRNSTechnology Acquisition
10th Apr 20157:00 amRNSAppointment of Nominated Adviser and Joint Broker
7th Apr 20153:08 pmRNSAIM Disclosure
2nd Apr 20157:00 amRNSTechnology Acquisition
24th Mar 20157:00 amRNSStrategic Alliance
11th Feb 20157:00 amRNSStrategic Alliance
6th Feb 20157:00 amRNSIssue of Shares
27th Jan 20157:01 amRNSTechnology acquisition
20th Jan 20157:00 amRNSNew Client Wins
15th Jan 20157:00 amRNSNew Client Wins
2nd Dec 20147:00 amRNSStrategic Alliance
21st Nov 20147:00 amRNSTrading Update
28th Aug 20147:00 amRNSUnaudited Interim Results
23rd Jul 20142:51 pmRNSAcquisition of InventionEvaluator.com
23rd May 20147:00 amRNSTeam Expansion & Opening Of New Offices
9th May 20149:54 amRNSHolding(s) in Company
15th Apr 20147:00 amRNSScience Advisory Board Appointment
8th Apr 20141:25 pmRNSHolding in Company
8th Apr 20147:00 amRNSTekcapital Announces Strategic Partnership
4th Apr 20148:00 amRNSFirst Day Of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.